TCI Wealth Advisors’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
KGAMU
WPM
GEH
ACM
TCI Wealth Advisors's CDLX Position: Q4 2022 in Review
TCI Wealth Advisors sold out of Cardlytics (CDLX) in Q4 2022, closing a stake of 7 shares — an estimated $1K sold.
TCI Wealth Advisors first reported a position in CDLX in Q2 2019 and held it in 7 quarters. The position peaked at $10K in Q4 2021. 121 funds tracked by Wall St. Rank hold CDLX as of Q4 2022.
- TCI Wealth Advisors reported no remaining Cardlytics position as of Q4 2022 after selling out during the quarter.
- TCI Wealth Advisors sold 7 Cardlytics shares in Q4 2022, an estimated $1K.
- TCI Wealth Advisors first reported a position in Cardlytics in Q2 2019 and held it in 7 quarters.
- TCI Wealth Advisors's Cardlytics position peaked at $10K in Q4 2021.
- 121 funds tracked by Wall St. Rank held Cardlytics as of Q4 2022.
Based on TCI Wealth Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.